Higher incidence of paediatric autoimmune liver disease post-COVID
WTF!
😡UK paper blames lockdown ‘isolation’ for exploding kids’ autoimmune liver disease, while quietly noting viral triggers were ‘low.’ Immunity debt is scientifically dead. SarsCoV2 isn’t.
➡️Leeds Children’s Hospital’s retrospective review of newly diagnosed paediatric autoimmune liver disease (AILD) from 2015–2024 found a clear post-2020 surge versus the pre-COVID period, largest for type-1 autoimmune hepatitis (AIH-1), with smaller rises in primary sclerosing cholangitis (PSC) and overlap/ASC syndromes.
➡️The study:
- Children presented older (especially AIH-1), more frequently with decompensated disease, and PSC cases showed more new inflammatory bowel disease.
- Documented viral co-infections, including COVID-19, were low
- No severe COVID or PIMS-TS cases.
- The authors blame “immune dysregulation in susceptible individuals following long periods of social isolation and the lifting of COVID lockdown measures.”
➡️Flaws and why the immunity-debt claim is scientifically untrue:
- This is a crude before/after hospital series with zero individual exposure data, serology, or controls for SARSCoV2 itself. It cannot separate lockdown effects from the virus that is already proven to trigger autoimmunity through molecular mimicry, persistent antigen, and direct immune dysregulation. Low concurrent viral detection does not exclude prior or occult infection. Referral changes, delayed presentation, and ascertainment bias are ignored. Age and ethnic shifts go unexplained. “Immunity debt” (or the related hygiene-hypothesis stretch) has been repeatedly shown to be false: reduced pathogen exposure does not produce autoimmune surges, while the same post-2020 rises track SARSCoV2 infection and vaccination far more closely. 😡The narrative is a classic post-hoc excuse completely lacking in scientific evidence!
➡️Surprisingly, they CONTRADICT themselves with their “HIGHLIGHTS” section!
- The “What is Known” section explicitly states a strong association between COVID-19 and autoimmunity, higher adult AIH post-COVID, higher paediatric type 1 diabetes and coeliac disease post-COVID, and more aggressive post-COVID autoimmune phenotypes.
- The “What is New” section then reports higher AIH-1/overlap/PSC incidence post-2020, older age at presentation, and higher rates of concomitant viral infections in the newly diagnosed AIH cases.
- But still the paper’s conclusion pivots to “immune dysregulation… following long periods of social isolation and the lifting of COVID lockdown measures.”
‼️This is not a minor tension. It is a direct internal contradiction: the data they highlight point toward SARSCoV2 (known to drive autoimmunity via molecular mimicry, persistent antigen, and immune dysregulation), while the interpretive narrative retreats to reduced pathogen exposure from lockdowns, a hypothesis repeatedly shown to be false.
‼️This paper simply recycles to deflect from the far stronger and better-supported role of SARSCoV2 itself.😡😡
➡️Please file vertically!
onlinelibrary.wiley.com/doi/…